Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors

Antimicrob Agents Chemother. 1994 May;38(5):1085-9. doi: 10.1128/AAC.38.5.1085.

Abstract

Sixteen Escherichia coli clinical isolates which were resistant to ampicillin and amoxicillin-clavulanate but susceptible to cephalothin were studied. Eight strains showed the presence of a beta-lactamase which comigrates with reference OXA-1 enzyme. The eight other strains produced different TEM-1 derivatives which had in common a higher Km for penicillins and a higher 50% inhibitory concentration for the beta-lactamase inhibitors. By oligotyping and sequencing of PCR products, it was shown that Ser (AGC) (TEM-30; also called TRI-1) in three strains and Cys (TGC) (TEM-31; also called TRI-2) in one strain were substituted for Arg-241 (CGC), that Leu (CTG) (TEM-33) and Val (GTG) (TEM-34) in one strain each were substituted for Met-67 (ATG), and that in other mutants the two latter substitutions occurred together with the substitution of Asp (GAT) (TEM-35 and TEM-36) for Asn-272 (AAT). Therefore, different sets of amino acid substitutions of TEM-1 can be found in clinical isolates and lead to resistance to beta-lactamase inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amoxicillin / pharmacology
  • Base Sequence
  • Cephalothin / pharmacology
  • Clavulanic Acid
  • Clavulanic Acids / pharmacology
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology*
  • Escherichia coli / genetics
  • Escherichia coli Infections / microbiology*
  • Humans
  • Kinetics
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Point Mutation
  • Polymerase Chain Reaction
  • beta-Lactamase Inhibitors
  • beta-Lactamases / biosynthesis*

Substances

  • Clavulanic Acids
  • beta-Lactamase Inhibitors
  • Clavulanic Acid
  • Amoxicillin
  • beta-lactamase OXA-2
  • beta-Lactamases
  • beta-lactamase TEM-1
  • Cephalothin